

Kriya Therapeutics, a gene therapy firm, has raised $80.5 million in Series A financing. The investors included QVT, Dexcel Pharma, Foresite Capital, Bluebird Ventures, Narya Capital, Amplo, Paul Manning, and Asia Alpha.
Source: Press Release
Kriya Therapeutics, a gene therapy firm, has raised $80.5 million in Series A financing.
Kriya Therapeutics, a gene therapy firm, has raised $80.5 million in Series A financing. The investors included QVT, Dexcel Pharma, Foresite Capital, Bluebird Ventures, Narya Capital, Amplo, Paul Manning, and Asia Alpha.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination